Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

BAX vs PEN: stock comparison and AI forecast

Baxter International Inc (BAX) and Penumbra Inc (PEN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Surgical & Medical Instruments & Apparatus

BAX Baxter International Inc

Price
$24.22 +45.7% · 6M
Market Cap
$12.52B
P/E Ratio
–
Size
large-cap
AI Forecast
Full analysis →
NYSE · Surgical & Medical Instruments & Apparatus

PEN Penumbra Inc

Price
$321.34 -1.0% · 6M
Market Cap
$12.66B
P/E Ratio
80.9x
Size
large-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-04 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

100120140160
BAX +45.7% PEN -1.0%
BAX · PEN

Key facts

  • BAX and PEN have similar market capitalizations ($12.52B and $12.66B).
  • Over the last six months BAX returned +45.7% and PEN -1.0%.
  • PEN turns 10.1% of its revenue into net income, against -6.2% for BAX.
  • BAX carries 1.99 times debt per unit of equity, against 0.28 times for PEN.
  • BAX yields 0.81% in dividends; PEN pays none.
  • Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricBAXPEN
Market Cap$12.52B$12.66B
P/E Ratio–80.94x
P/B Ratio1.93x7.99x
Dividend Yield0.81%–
EPS$-1.21$3.97
Book Value/Share$12.58$40.20
Revenue/Share$22.46$39.61
FCF/Share–$5.08

Profitability & Margins

MetricBAXPEN
ROE-11.1%9.9%
ROA-3.7%7.8%
ROIC-1.4%10.6%
Gross Margin30.1%68.0%
Operating Margin-1.9%12.1%
Net Margin-6.2%10.1%
EBT Margin-1.6%13.3%
Tax Rate-231.0%24.4%

Financial Health

MetricBAXPEN
Current Ratio1.79x5.89x
Quick Ratio1.19x3.92x
D/E Ratio1.99x0.28x
Financial Leverage2.99x1.28x
Interest Coverage-2.5x–
Working Capital$3.02B$1.14B

Cash Flow

MetricBAXPEN
Operating Cash Flow$1.64B$261M
Free Cash Flow–$200M
Capital Spending–-$61M
OCF Growth YoY119.0%28.4%
FCF Growth YoY–31.2%
FCF/Sales–12.8%
CapEx/Sales–3.9%

Operational Efficiency

MetricBAXPEN
Asset Turnover0.60x0.77x
Receivables Turnover6.5x8.0x
Inventory Turnover3.5x1.1x
Fixed Assets Turnover4.0x10.0x
Days Sales Outstanding56 days46 days
Days Inventory103 days335 days
Payables Period46 days31 days
Cash Conversion Cycle113 days350 days

Income Statement

MetricBAXPEN
Total Revenue$11.61B$1.56B
Operating Income-$221M$189M
Net Income-$723M$157M
R&D Expense$519M$95M
SG&A Expense$2.95B$777M
Cost of Goods Sold$8.12B$500M

Dividend & Shareholder Information

MetricBAXPEN
Dividends Per Share$0.20–
Shares Outstanding517M39M
Net Income Growth–-4.3%
EPS Growth–-11.4%
FAQ

BAX vs PEN: stock comparison and AI forecast

Which is bigger, BAX or PEN?

BAX and PEN have similar market capitalizations ($12.52B and $12.66B).

Which stock performed better over the last six months, BAX or PEN?

Over the last six months BAX returned +45.7% and PEN -1.0%.

Which one does Intratio's AI model rank higher, BAX or PEN?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.